Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada
Author:
Walker Mariah,Lake Stephanie,Tempero José,Ong Kaye,Lucas Philippe
Abstract
Objective: An increasing number of Canadians are registering as authorized users of medical cannabis. Older patients comprise a growing subset of this population; however, relatively little information exists around age-related patterns of medical cannabis use. Methods: The Canadian Cannabis Patient Survey (CCPS) is a large cross-sectional survey of authorized medical cannabis patients in Canada. This publication summarizes the results of the CCPS 2021, with a focus on age-related outcomes and the elderly sub-population. Results: The survey was completed by 2,697 patients. The mean age of participants was 54.3 years of age and the proportion of female respondents was 49.1%. Among older patients, pain was the most common symptom, while anxiety was the most common symptom reported by younger patients. Older patients exhibited a significant preference for oral administration over inhalation of medical cannabis when compared to younger patients, respectively (p>0.05). Among patients taking prescription opioids, most of whom were older patients, 54% reported a decrease in use concurrent with medical cannabis. Conclusions: Older patients comprise a growing subset of medical cannabis patients, which is also reflected in CCPS participants over time. This patient population exhibits different patterns of use compared to their younger counterparts, preferring high CBD orally ingested formulations, which they use primarily to treat pain-related illnesses/symptoms. Overall, study participants reported that cannabis had a high degree of efficacy in alleviating their illness/symptoms, and many reported a reduction in their use of prescription opioids, alcohol, tobacco, and other substances.
Publisher
Research Society on Marijuana
Reference29 articles.
1. Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018). Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain, 19(1), 37. https://doi.org/10.1186/s10194-018-0862-2 2. Bhaskar, A., Bell, A., Boivin, M., Briques, W., Brown, M., Clarke, H., Cyr, C., Eisenberg, E., De Oliveira Silva, R.F., Frohlich, E., Georgius, P., Hogg, M., Horsted, T.I., Maccallum, C.A., Müller-Vahl, K.R., O'Connell, C., Sealey, R., Seibolt, M., Sihota, A., Smith, B.K., Sulak, D., Vigano, A., Moulin, D.E., 2021. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research 3.. https://doi.org/10.1186/s42238-021-00073-1 3. Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain, 17(6), 739-744. https://doi.org/10.1016/j.jpain.2016.03.002 4. Bruce, D., Grove, T. J., Foster, E., & Shattell, M. (2020). Gender differences in medical cannabis use: Symptoms treated, physician support for use, and prescription medication discontinuation. Journal of Women's Health, 30(6), 857-863. https://doi.org/10.1089/jwh.2020.8437 5. Evaluation of patient reported safety and efficacy of cannabis from a survey of medical cannabis patients in Canada [Original Research];Cahill;Frontiers in Public Health 9 https,2021
|
|